Literature DB >> 19122032

Diagnostic utility of different MRI and MR angiography measures in Fabry disease.

A Fellgiebel1, I Keller, D Marin, M J Müller, I Schermuly, I Yakushev, J Albrecht, H Bellhäuser, M Kinateder, M Beck, P Stoeter.   

Abstract

BACKGROUND: Neurologic hallmarks of Fabry disease (FD) include small fiber neuropathy as well as cerebral micro- and macroangiopathy with premature stroke. Cranial MRI shows progressive white matter lesions (WML) at an early age, increased signal intensity in the pulvinar, and tortuosity and dilatation of the larger vessels. To unravel the most promising imaging tool for the detection of CNS involvement in FD we compared the diagnostic utility of the different MR imaging findings.
METHODS: Twenty-five clinically affected patients with FD (age 36.5 +/- 11.0) and 20 age-matched controls were investigated by structural MRI, MR angiography, and diffusion tensor imaging (DTI). Individual WML volumes, global mean diffusivity (MD), and mean cerebral artery diameters were determined.
RESULTS: Using receiver operating characteristic analyses, enlarged diameters of the following cerebral arteries significantly separated patients with FD from controls: middle cerebral artery: area under curve (AUC) = 0.75, p = 0.005; posterior cerebral artery: AUC = 0.69, p = 0.041; carotid artery: 0.69, p = 0.041; basilar artery: AUC = 0.96, p < 0.0005. A total of 87% of the individuals were correctly classified by basilar artery diameters (sensitivity 95%, specificity 83%). WML volumes and global MD values did not significantly separate patients from controls.
CONCLUSIONS: With an accuracy of 87%, basilar artery diameters were superior to all other MR measures for separating patients with Fabry disease (FD) from controls. Future studies should adopt basilar artery measurements for early detection and monitoring of brain involvement in FD. Moreover, further investigations should reveal if the dilated vasculopathy in FD could be a screening marker to detect FD in a cohort of other cerebrovascular diseases, especially in cryptogenic stroke.

Entities:  

Mesh:

Year:  2009        PMID: 19122032     DOI: 10.1212/01.wnl.0000338566.54190.8a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease.

Authors:  Andreas Fellgiebel; Dominik O Wolf; Edwin Kolodny; Matthias J Müller
Journal:  J Inherit Metab Dis       Date:  2011-09-20       Impact factor: 4.982

2.  Structural integrity of the corpus callosum predicts long-term transfer of fluid intelligence-related training gains in normal aging.

Authors:  Dominik Wolf; Florian Udo Fischer; Johanna Fesenbeckh; Igor Yakushev; Irene Maria Lelieveld; Armin Scheurich; Ingrid Schermuly; Lisa Zschutschke; Andreas Fellgiebel
Journal:  Hum Brain Mapp       Date:  2012-09-11       Impact factor: 5.038

3.  Cognitive and psychological functioning in Fabry disease.

Authors:  Linda Sigmundsdottir; Michel C Tchan; Alex A Knopman; Graham C Menzies; Jennifer Batchelor; David O Sillence
Journal:  Arch Clin Neuropsychol       Date:  2014-11       Impact factor: 2.813

Review 4.  Stroke and Fabry disease.

Authors:  Miguel Viana-Baptista
Journal:  J Neurol       Date:  2011-10-27       Impact factor: 4.849

5.  Increased resting cerebral blood flow in adult Fabry disease: MRI arterial spin labeling study.

Authors:  Po Phyu; Aine Merwick; Indran Davagnanam; Fay Bolsover; Fatima Jichi; Claudia Wheeler-Kingshott; Xavier Golay; Deralynn Hughes; Lisa Cipolotti; Elaine Murphy; Robin H Lachmann; David John Werring
Journal:  Neurology       Date:  2018-03-21       Impact factor: 9.910

6.  Brain MR Imaging Findings of Cardiac-Type Fabry Disease with an IVS4+919G>A Mutation.

Authors:  H-J Lee; S-C Hung; T-R Hsu; S-C Ko; T Chui-Mei; C-C Huang; D-M Niu; C-P Lin
Journal:  AJNR Am J Neuroradiol       Date:  2016-02-11       Impact factor: 3.825

7.  Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy.

Authors:  Alessandro Salviati; Alessandro P Burlina; Walter Borsini
Journal:  Neurol Sci       Date:  2010-03-19       Impact factor: 3.307

8.  Redefining the Pulvinar Sign in Fabry Disease.

Authors:  S Cocozza; C Russo; A Pisani; G Olivo; E Riccio; A Cervo; G Pontillo; S Feriozzi; M Veroux; Y Battaglia; D Concolino; F Pieruzzi; R Mignani; P Borrelli; M Imbriaco; A Brunetti; E Tedeschi; G Palma
Journal:  AJNR Am J Neuroradiol       Date:  2017-10-19       Impact factor: 3.825

Review 9.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

10.  A Case of Cerebral Aneurysmal Subarachnoid Hemorrhage in Fabry's Disease.

Authors:  Youn Hyuk Chang; Sung-Kyun Hwang
Journal:  J Korean Neurosurg Soc       Date:  2013-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.